198 related articles for article (PubMed ID: 11135387)
21. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S
Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929
[TBL] [Abstract][Full Text] [Related]
22. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
23. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
Zhao Y; Kerscher N; Eysel U; Funke K
J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
[TBL] [Abstract][Full Text] [Related]
24. Effects of selective dopamine receptor compounds on single, spontaneously-active neostriatal neurons.
Nantwi KD; Schoener EP
Gen Pharmacol; 1994 Nov; 25(7):1439-43. PubMed ID: 7896058
[TBL] [Abstract][Full Text] [Related]
25. Spinal Dopaminergic Mechanisms Regulating the Micturition Reflex in Male Rats with Complete Spinal Cord Injury.
Qiao Y; Brodnik ZD; Zhao S; Trueblood CT; Li Z; Tom VJ; España RA; Hou S
J Neurotrauma; 2021 Mar; 38(6):803-817. PubMed ID: 33297828
[TBL] [Abstract][Full Text] [Related]
26. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Coronas V; Krantic S; Jourdan F; Moyse E
Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
[TBL] [Abstract][Full Text] [Related]
27. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Yoshimura N; Mizuta E; Kuno S; Sasa M; Yoshida O
Neuropharmacology; 1993 Apr; 32(4):315-21. PubMed ID: 8098860
[TBL] [Abstract][Full Text] [Related]
28. Role of dopamine D1 and D2 receptors in the nucleus accumbens in jaw movements of rats: a critical role of the shell.
Cools AR; Miwa Y; Koshikawa N
Eur J Pharmacol; 1995 Nov; 286(1):41-7. PubMed ID: 8566150
[TBL] [Abstract][Full Text] [Related]
29. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors.
Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N
Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937
[TBL] [Abstract][Full Text] [Related]
30. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
[TBL] [Abstract][Full Text] [Related]
31. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
Garrett BE; Holtzman SG
Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
[TBL] [Abstract][Full Text] [Related]
32. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
33. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
Williams JE; Sutherland JV; Woolverton WL
Behav Neural Biol; 1990 May; 53(3):378-92. PubMed ID: 1972014
[TBL] [Abstract][Full Text] [Related]
35. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
Koshikawa N; Kitamura M; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
[TBL] [Abstract][Full Text] [Related]
36. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
[TBL] [Abstract][Full Text] [Related]
37. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
LaHoste GJ; Yu J; Marshall JF
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
[TBL] [Abstract][Full Text] [Related]
38. Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 1. Food deprivation.
Hobbs DJ; Koch JE; Bodnar RJ
Pharmacol Biochem Behav; 1994 Sep; 49(1):197-204. PubMed ID: 7816874
[TBL] [Abstract][Full Text] [Related]
39. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
David HN; Abraini JH
Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
[TBL] [Abstract][Full Text] [Related]
40. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model.
Rehders JH; Löscher W; Richter A
Neuroscience; 2000; 97(2):267-77. PubMed ID: 10799758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
